BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Par Pharmaceutical Companies, Inc. (Formerly Pharmaceutical Resources, Inc.) 

One Ram Ridge Road

Spring Valley  New York  10977  U.S.A.
Phone: 914-425-7100 Fax: 914-425-7907


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Par Pharmaceutical Companies, Inc. (PRX) Names Terrance J. Coughlin Chief Operating Officer 4/1/2014 6:46:33 AM    More...
Par Pharmaceutical Companies, Inc. (PRX) Announces Quarterly Conference Call 11/5/2013 10:08:05 AM    More...
Par Pharmaceutical Companies, Inc. (PRX)'s Karen O'Connor Receives 2013 Cardinal Health Supply Chain Excellence Award 10/25/2013 9:55:57 AM    More...
Par Pharmaceutical Companies, Inc. (PRX) Begins Shipment of Generic Kapvay® 10/7/2013 10:29:29 AM    More...
Par Pharmaceutical Companies, Inc. (PRX) Begins Shipment of KHEDEZLA (desvenlafaxine) Extended-Release Tablets, 50 mg and 100 mg 9/23/2013 9:50:52 AM    More...
Horizon Pharma, Inc. (HZNP) Announces Settlement of DUEXIS® Patent Litigation With Par Pharmaceutical Companies, Inc. (PRX) 8/22/2013 9:08:53 AM    More...
Par Pharmaceutical Companies, Inc. (PRX) Receives Approval of sANDA for Bupropion Hydrochloride Extended-Release Tablets USP (XL), 300 mg 8/20/2013 10:20:44 AM    More...
Par Pharmaceutical Companies, Inc. (PRX) Announces Quarterly Conference Call 8/5/2013 7:50:24 AM    More...
Par Pharmaceutical Companies, Inc. (PRX) Begins Shipment of Generic Trilipix® 7/18/2013 10:20:56 AM    More...
Par Pharmaceutical Companies, Inc. (PRX) Begins Shipment of Generic Atacand® 5/22/2013 10:19:59 AM    More...
12345678910...